Loading clinical trials...
Loading clinical trials...
Showing 1-3 of 3 trials
NCT07282301
Patients with femoropopliteal arterial lesions requiring debulking procedures. The objective of this study is Evaluation of the clinical outcomes of the Embolic Protection System for preventing distal embolism during femoropopliteal endovascular debulking procedures (The EPISODE study).
NCT07136883
The goal of this clinical trial is to learn if using a scoring balloon to prepare the femoropopliteal (FP) segment before drug-coated balloon treatment works better than using a regular balloon (called plain old balloon angioplasty, or POBA). This study includes only people with critical limb ischemia (CLI). The main questions it aims to answer are: 1. Does using a scoring balloon reduce the need for a bailout stent during the procedure? 2. Does a scoring balloon help keep the artery open longer? 3. Is the cost of the scoring balloon procedure similar to the cost of the POBA procedure? Participants will: * Receive either a scoring balloon or POBA to prepare the femoropopliteal segment * Then be treated with a drug-coated balloon in the same segment * Be monitored during the procedure to see if a bailout stent is needed * Have follow-up visits to see if the artery remains open
NCT00798850
Intermittent Claudication (IC)is a common condition characterised by pain in the muscles of the legs on exertion caused by "hardening of the arteries" and a reduced blood supply. The investigators know that the vast majority of people suffering from this condition remain stable and do not deteriorate, and thus in general the viability of legs is not at risk. The main aim of treatment, therefore, is to try and improve walking thus reducing the impact this problem has on patients life style. There are many methods of management of intermittent claudication, but the investigators do not know which produces the best results. This study aims to compare the short and medium term outcomes of exercise programmes, percutaneous transluminal angioplasty and a combination of the two treatments for patients with intermittent claudication.